SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL

Jun-18

Cardiovascular Pharmacoepidemiology

AUTHORS : Dr Matthew A Cavender, University of North Carolina at Chapel Hill, Burnett-Womack Building, 160 Dental Circle, CB 7075, Chapel Hill, North Carolina 27599 – Email: matt.cavender@unc.edu – Profile: https://www.med.unc.edu/medicine/directory/matthew-cavender/

JOURNAL : Journal of the American College of Cardiology

REFERENCE: 71(22):2497-2506

DOI : 10.1016/j.jacc.2018.01.085

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more